Efficient infection of primitive hematopoietic stem cells by modified adenovirus. - Wikidata - wikimedia - TriplyDB

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

http://www.wikidata.org/entity/Q33182157

about

A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression.Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease.CD8+ T-cell recognition of human cytomegalovirus latency-associated determinant pUL138.Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma.Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma.Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons.mRNA Structural constraints on EBNA1 synthesis impact on in vivo antigen presentation and early priming of CD8+ T cells.A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells Potent Antitumor Activity Generated by a Novel Tumor Specific Cytotoxic T Cell.Advances in gene transfer into haematopoietic stem cells by adenoviral vectors.Intracellular Acidosis Promotes Mitochondrial Apoptosis Pathway: Role of EMMPRIN Down-regulation via Specific Single-chain Fv Intrabody Biotinylated gene therapy vectors.Species D adenoviruses as oncolytics against B-cell cancers.Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation.A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma.Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes.T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients.Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.Bone marrow subsets differentiate into endothelial cells and pericytes contributing to Ewing's tumor vessels.Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors.VEGF165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy.In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation.Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells.A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette.High Efficiency Ex Vivo Gene Transfer to Primary Murine B Cells Using Plasmid or Viral Vectors Tightly regulated gene expression in human hematopoietic stem cells after transduction with helper-dependent Ad5/35 vectors.Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes.In Vivo Hematopoietic Stem Cell Transduction.A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells.Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector.Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type.Liposome-mediated transfer of vascular endothelial growth factor cDNA augments survival of random-pattern skin flaps in the rat.Distinctive gene transduction efficiencies of commonly used viral vectors in the retina.A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy.Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies.

P2860

Q24530140-ECBD1DDE-4A25-4F1E-AA88-19E6BBDEB4CE Q30830095-CF1A894F-7A62-49A2-AC19-12C6A44BB4CA Q33878986-E435A2E6-222E-4577-9C8D-4650D56FBE70 Q34018782-EAB6635F-D2D0-479F-9C74-8D899952D3CC Q34102273-77FD476D-C4CE-41AA-95DE-E917DB94978B Q34313075-5EC1578F-B99D-4CD4-A75E-0B81C37E29DC Q34317937-6D429F0D-7061-44A8-8D6F-8619215E2798 Q34329158-18924872-DE21-4A42-AEAC-24B2E1D6B085 Q34794162-78FCB231-9EB5-42D2-BF43-365459C76A57 Q35040833-32C8F24F-16FC-4917-A4E5-58F12974AA17 Q35051275-DFFDFE8C-9371-4A82-BC08-125B330EBCF8 Q35207516-247C71DF-2580-485A-820C-8800DEA8E1F3 Q35511348-D31B696C-8D14-4C9C-96B5-21C78274E473 Q35664973-1746E29C-607C-4725-98E4-DF045D526581 Q35857642-83D68BCE-25A4-456A-B45E-3AA8C40EBC46 Q36267161-60AA8CEE-0FDB-4AF9-9118-EF7C63CF0795 Q36388658-9C4504D5-2CF5-411D-80BD-376BDBDDD1BC Q36399179-2848AA71-2D97-4A0D-8F4D-B98657085E8D Q36740440-2D66C05E-2140-41B6-9F9C-DBA6E338BD06 Q36893512-98DE2675-B435-497B-AB3F-ED4E592FE288 Q36983725-2D14C216-B0E8-475E-954E-F9F5502F97C7 Q36983772-5D15D474-8F0C-49FF-85B6-EF87D04A26A3 Q37098062-6850254A-683B-4230-BF14-1C2C8504F46F Q37394036-274CFEC7-8FFB-4F46-A7CD-02934EECB37A Q37414729-A5896A8A-85E2-40D6-880D-CEAB184D23F1 Q37696350-4896A474-3C8C-4BE7-90F2-AAFB815C9D28 Q39320579-F029B655-8CC0-4443-89B6-5AB3FE9EAAE6 Q39553529-FE9D1E98-7519-4662-8C15-C1EFCBC701DB Q39994382-DD7A85A3-0427-4F75-B387-D825FB37C74D Q39997530-1BCCB0DD-58E0-42FB-A128-2B136543CB67 Q40045829-32C66307-B6D3-49F8-A341-0EE1FF922F97 Q40223632-4108CD67-C18A-4487-8AA2-DEFCAAE6B4FD Q44957854-E9934DA8-B237-4E5C-9829-DB6C6AEA48DE Q45862548-305D74F9-722F-4C9A-901D-09B5330758B9 Q45862722-16849DF5-6F2A-4CBD-9640-DBCA0E1C92A2 Q45864080-C7029285-1734-4FD7-A9F4-B8696E9A72B3 Q45872986-67738C90-2404-4DFC-BFEA-3AEB35740FF2 Q45874652-4B3DF3BA-6EC3-4621-9680-1A6EA735D39B Q49963933-7AFAC54E-E16D-453A-9AC7-81CF9F00140A Q55333613-E91BF68A-5D08-40A9-8895-57B5DB746118

P2860

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

http://www.wikidata.org/entity/Q33182157

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

@ast

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

@en

type

label

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

@ast

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

@en

prefLabel

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

@ast

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

@en

P1433

Q33182157-EF96A0D8-5D27-490C-A9EE-4B7B37CBFD8C

P1476

Q33182157-01F0B693-CE8A-4932-9978-880AA69E0CC0

P2093

Q33182157-2C065917-F3C0-443D-AF89-45A4A5A6B332

Q33182157-5BEEB0D5-C630-4F8B-AC01-73B1CDED1854

Q33182157-6971A1D1-D0E5-4A77-99CF-3F7E2FE6F043

Q33182157-80AD51FA-1CE5-4B3B-BFF4-CF2821F4ADA6

Q33182157-B0AB0A53-832B-4B5F-AD3A-2D64B4EFA478

Q33182157-BC3AF284-A534-4548-ACA7-37F50DB6C367

Q33182157-E246F12B-B68B-463C-BD30-97B43AB04335

P2860

Q33182157-016FDFE8-EEAE-4FDE-B4BF-DB31613EBB96

Q33182157-0562BD67-09F6-4F79-BE68-450F31DE6002

Q33182157-069EE382-4083-4F6D-97B3-8FB4B5CB0751

Q33182157-1E552A11-7A44-4B28-A7B8-1009812B0408

Q33182157-20A3745D-BEAC-4BB4-94C9-B2D72402D0E1

Q33182157-2419AC55-F522-4BD9-B278-17B87F55DB46

Q33182157-2F2A3F15-EDD5-49EB-95C9-39733D3B0226

Q33182157-41439494-CD37-478B-B672-B150155B0ED1

Q33182157-4196C82F-7D0F-4DF2-BFDB-8DA5C9C4FB5B

Q33182157-456F30BA-F119-4FDC-88FE-A75D133F1C49

P2888

Q33182157-15D6F6CE-5315-4786-915F-92F3777369A8

P304

Q33182157-4C954F34-391F-4CE7-944B-BB6398F91359

P31

Q33182157-23310073-1BAF-4AD3-ABE6-6CF90B9393CD

P356

Q33182157-565EB92B-E4B4-4DF7-BB66-461F39B32709

P433

Q33182157-CD25CD3E-E18A-492E-9E7F-68E93DAEE55F

P478

Q33182157-1EC9545C-232A-4643-9810-27765DAD73D4

P577

Q33182157-FD9F2366-688C-413A-915A-2D00FB9598DF

P5875

Q33182157-1A8DD920-41E1-4128-8FEF-71A457F3655A

P6179

Q33182157-C8482A6F-67F2-4288-9743-D5A70F5CFBEE

P698

Q33182157-65DA5B02-9D6C-4E7D-AA09-36C165531342

P921

Q33182157-F64F4261-80AB-4D0E-B97B-368582855B7B

P356

P1433

P1476

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

@en

P2093

Brenner M

http://www.w3.org/2001/XMLSchema#string

Davis A

http://www.w3.org/2001/XMLSchema#string

Heslop HE

http://www.w3.org/2001/XMLSchema#string

Lieber A

http://www.w3.org/2001/XMLSchema#string

Onishi H

http://www.w3.org/2001/XMLSchema#string

Shayakhmetov D

http://www.w3.org/2001/XMLSchema#string

Yotnda P

http://www.w3.org/2001/XMLSchema#string

P2860

CD40 ligand in CLL pathogenesis and therapy

A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells

Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.

The role of CD40 in peripheral T cell tolerance and immunity.

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors

P2888

P304

930-937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.GT.3301488

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11914927

http://www.w3.org/2001/XMLSchema#string

P6179

1021153685

http://www.w3.org/2001/XMLSchema#string

P698

11426333

http://www.w3.org/2001/XMLSchema#string

P921